Allogene Therapeutics ALLO Growth Metrics (2018-2026)

NASDAQ ALLO
$1.33 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Allogene Therapeutics Quarterly Growth Metrics

Periods 33 quarters
Latest Jun 2026

Allogene Therapeutics reported asset growth of 16.89% for the quarter ended Jun 2026. These growth metrics cover 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
-11.72%-14.42%-17.04%-15.19%-17.12%-21.82%-23.31%-19.11%-20.24%-21.76%-21.83%-16.32%-17.42%-14.64%-13.37%-27.25%-25.35%-24.20%-22.05%16.89%
Assets Growth (3y)
35.35%10.74%9.29%9.19%8.75%4.60%2.90%-15.00%-16.43%-19.40%-20.77%-16.89%-18.27%-19.47%-19.62%-21.03%-21.07%-20.30%-19.18%-10.72%
Assets Growth (5y)
10.39%-3.64%-4.79%-2.50%-3.27%-5.23%-5.90%-17.86%-18.49%-19.47%-19.61%-13.36%
Assets (QoQ)
-4.21%-2.63%-6.92%-2.30%-6.40%-8.15%-8.70%3.05%-7.71%-9.89%-8.79%10.32%-8.93%-6.86%-7.42%-7.36%-6.55%-5.43%-4.80%38.93%
Capital Expenditures Growth (1y)Capex Growth (1y)
-77.05%-86.14%-47.73%-72.70%-42.79%71.94%3.04%-1.92%6.71%-30.47%-23.10%-6.25%17.39%7.37%8.13%7.41%-4.32%-6.31%-2.53%3.30%
Capital Expenditures Growth (3y)Capex Growth (3y)
53.42%25.79%-28.93%-26.83%-47.29%-33.16%-33.58%-42.56%-48.06%-45.07%-25.46%-36.92%-10.51%8.68%-5.02%-0.42%6.22%-11.24%-6.76%1.32%
Capital Expenditures Growth (5y)Capex Growth (5y)
4.69%17.13%18.93%-22.23%-18.47%-28.76%-25.93%-24.60%-28.20%-30.91%-30.11%-15.28%-22.56%
Capital Expenditures (QoQ)Capex (QoQ)
-59.79%-45.89%44.26%-13.01%-15.75%62.64%-13.55%-17.20%-8.33%5.96%-4.38%0.94%14.78%-3.09%-3.71%0.27%2.25%-5.10%0.19%6.26%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
20.16%-5.47%-64.32%-57.03%-60.87%-64.28%30.07%61.14%-6.87%34.33%-53.57%10.28%-26.00%-9.54%-16.82%-69.34%-26.20%-31.28%-28.61%-26.19%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
31.72%23.31%-3.05%-5.16%-22.70%-29.29%-6.82%-17.97%-24.06%-23.17%-40.05%-8.60%-35.39%-24.29%-20.51%-18.32%-20.18%-5.83%-34.91%-37.04%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-3.59%-2.09%-11.26%8.68%-20.46%-15.55%-20.76%-28.52%-24.89%-22.37%-33.72%-29.61%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-14.98%-8.79%-51.24%13.64%-22.58%-16.75%77.58%40.78%-55.26%20.09%-38.62%234.39%-69.98%46.80%-43.56%23.26%-27.74%36.69%-41.36%27.44%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
115.61%31.70%-123.12%119.70%91.39%69.56%604.69%-68.24%-237.59%36.02%-80.40%334.81%-121.76%-18.57%-72.10%-41.25%115.71%-38.81%-579.08%-436.62%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
26.85%27.92%-38.91%6.69%-31.88%84.25%111.98%26.83%25.64%44.82%-38.85%44.76%-98.66%23.38%31.54%-6.74%-21.75%-12.16%-31.27%-119.66%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
53.47%35.90%17.24%-7.62%10.89%-24.28%47.27%19.25%16.02%16.47%8.64%-18.18%-51.57%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-47.09%124.78%-176.50%341.47%-53.91%99.14%127.71%-84.81%-299.69%296.87%-67.19%237.11%-201.85%172.29%-88.76%609.76%-72.77%181.63%-188.03%-398.71%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-30.04%-355.50%-38.33%-3.31%2.50%-36.67%2.34%-45.44%-16.53%13.51%16.12%-2.80%20.56%31.67%5.31%38.62%32.70%24.79%75.60%18.02%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-41.84%-28.37%-31.14%-19.55%-14.27%-7.30%-17.76%-32.29%-13.89%-75.27%-4.26%-15.59%3.36%6.87%8.12%2.82%14.59%23.69%42.13%19.73%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-568.29%-59.21%-26.52%-20.11%-13.06%-20.63%-6.68%6.10%-5.34%-7.87%4.61%-22.57%23.51%4.92%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-18.72%7.04%-50.18%37.67%-12.05%-30.30%-7.32%7.18%10.23%3.28%-4.08%-13.76%30.62%16.81%-44.23%26.26%23.94%7.04%53.21%-147.78%
EBITDA Margin Growth (1y)
-19.56M4.30M-13.75M-35.90M-12.29M-23.56M2.12M-2.98M1.88M
EBITDA Margin Growth (3y)
-29.97M34.86M
EBITDA Margin Growth (5y)
15.60M
EBITDA Margin (QoQ)
0.32M15.38M-19.57M8.17M-17.73M-6.77M4.03M-3.09M7.94M-11.86M8.90M
EBIT Growth (1y)
-14.15%102.46%-141.00%-7.87%-6.23%-5,747.04%-23.84%-5.12%23.65%11.71%29.86%11.31%-13.93%28.93%6.21%20.46%37.44%29.90%29.30%17.42%
EBIT Growth (3y)
-51.84%27.07%-29.95%-18.57%-14.47%-14.29%-19.77%-8.44%2.53%-7.06%-27.92%-0.19%2.60%-234.53%6.60%9.48%18.36%23.95%22.52%16.48%
EBIT Growth (5y)
-107.16%9.82%-23.21%-20.83%-13.77%-9.22%-5.46%1.30%-2.48%2.09%7.98%9.37%-6.78%7.96%
EBIT Margin Growth (1y)
-20.51M4.17M-14.71M-37.08M-12.51M-24.64M1.93M-3.45M1.44M
EBIT Margin Growth (3y)
-31.58M36.51M
EBIT Margin Growth (5y)
16.04M
EBIT Margin (QoQ)
0.29M15.85M-20.52M8.55M-18.59M-6.52M4.04M-3.58M7.97M-11.89M8.94M
EBIT (QoQ)
-9.35%102.20%-4,787.40%4.25%-7.69%-16.83%-2.80%18.72%21.78%-35.10%18.34%-2.77%-0.48%15.72%-7.77%12.84%20.98%5.56%-8.70%-1.80%
EBT Growth (1y)
-16.74%102.76%-139.52%-8.37%-5.48%-5,046.54%-22.02%-0.60%30.33%15.80%33.97%13.44%-14.75%27.02%6.63%23.39%36.60%32.13%28.43%16.28%
EBT Growth (3y)
-21.11%27.28%-35.97%-22.60%-17.15%-15.24%-21.22%-7.98%4.98%-4.76%-24.50%1.91%5.52%-218.79%9.05%12.62%20.27%25.28%23.87%17.81%
EBT Growth (5y)
-106.30%10.66%-5.48%-20.82%-15.16%-9.92%-5.15%1.22%-1.89%3.55%9.00%10.65%-5.22%9.55%
EBT Margin Growth (1y)
-20.38M4.08M-14.42M-36.01M-11.95M-22.97M4.37M-1.53M3.22M
EBT Margin Growth (3y)
-29.11M34.80M
EBT Margin Growth (5y)
15.91M
EBT Margin (QoQ)
0.23M15.77M-20.39M8.47M-18.27M-5.83M3.67M-2.55M9.08M-11.73M8.42M
EBT (QoQ)
-9.76%102.45%-4,300.85%4.05%-6.83%-14.88%-3.63%20.89%26.02%-38.83%18.74%-3.70%1.92%11.70%-3.96%14.92%18.82%5.47%-9.63%0.47%
EPS (Basic) Growth (1y)
-9.59%100.06%-122.61%-6.43%-2.77%-107,421.07%-24.35%3.61%36.64%19.56%44.42%35.30%14.70%43.71%27.83%33.37%41.16%42.83%36.07%44.24%
EPS (Basic) Growth (3y)
62.37%26.00%-19.66%-10.67%-5.70%-4.01%-11.42%-0.71%10.64%21.25%-15.44%12.77%17.80%-687.25%20.69%25.38%31.75%36.27%36.47%37.82%
EPS (Basic) Growth (5y)
-47.53%43.34%48.95%12.31%-3.44%3.30%8.59%12.62%11.12%15.13%18.57%30.93%6.63%24.42%
EPS (Basic) (QoQ)
-8.45%100.11%-87,923.86%-0.70%-4.72%-15.89%-1.76%21.95%31.16%-47.12%29.69%9.14%9.25%2.91%9.85%16.11%19.87%5.65%-0.80%26.83%
EPS (Diluted) Growth (1y)
-9.59%100.06%-122.61%-6.43%-2.77%-107,421.07%-24.35%3.61%36.64%19.56%44.42%35.30%14.70%43.71%27.83%33.37%41.16%42.83%36.07%44.24%
EPS (Diluted) Growth (3y)
-4.01%-8.65%-0.71%10.64%21.25%-15.44%12.77%17.80%-687.25%20.69%25.38%31.75%36.27%36.47%37.82%
EPS (Diluted) Growth (5y)
12.62%12.45%15.13%18.57%30.93%6.63%24.42%
EPS (Diluted) (QoQ)
-8.45%100.11%-87,923.86%-0.70%-4.72%-15.89%-1.76%21.95%31.16%-47.12%29.69%9.14%9.25%2.91%9.85%16.11%19.87%5.65%-0.80%26.83%
FCF Margin Growth (1y)
-18.48M4.99M-7.71M-25.66M-5.05M-22.45M-7.92M-1.44M-3.26M
FCF Margin Growth (3y)
-26.79M29.55M
FCF Margin Growth (5y)
12.09M
FCF Margin (QoQ)
1.18M10.98M-18.49M11.32M-11.53M-6.96M2.12M-6.08M3.00M-0.49M0.30M
Free Cash Flow Growth (1y)FCF Growth (1y)
9.12%-63.77%-27.07%14.25%6.22%-38.64%2.05%-41.96%-15.97%14.69%16.51%-2.34%18.59%29.46%4.61%36.48%30.58%23.20%71.28%16.34%
Free Cash Flow Growth (3y)FCF Growth (3y)
-42.76%-28.22%-20.64%-11.06%0.56%-0.49%-9.06%-13.82%0.39%-24.66%-1.29%-7.60%3.98%5.86%7.95%2.64%13.14%22.69%38.85%18.38%
Free Cash Flow Growth (5y)FCF Growth (5y)
-576.13%-49.66%-25.91%-20.05%-7.50%-14.76%1.48%9.40%-0.65%0.84%10.99%-0.97%22.22%7.92%
Free Cash Flow (QoQ)FCF (QoQ)
-0.58%10.63%-49.85%36.34%-10.00%-32.12%-5.87%7.74%10.13%2.80%-3.60%-13.09%28.51%15.79%-40.11%24.69%21.87%6.84%47.61%-119.38%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
81.81%81.86%64.65%35.48%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-4.05%41.80%51.22%38.43%-3.79%-13.41%10.97%
Net Cash Flow Growth (1y)NCF Growth (1y)
71.41%-162.92%-265.94%186.27%35.24%21.50%154.08%288.89%-294.36%211.69%-166.87%166.87%-39.66%72.40%-2.01%-91.74%87.84%-42.15%34.75%-15.79%
Net Cash Flow Growth (3y)NCF Growth (3y)
17.60%-53.88%-206.45%-16.55%-34.77%-42.29%47.73%-32.30%9.95%-17.99%-37.51%122.08%-52.79%52.00%28.28%-5.02%12.52%46.03%-34.72%-42.96%
Net Cash Flow Growth (5y)NCF Growth (5y)
525.90%-20.81%-7.40%7.58%-63.50%43.24%-34.90%11.15%3.54%-41.53%34.13%-11.26%-19.13%21.27%
Net Cash Flow (QoQ)NCF (QoQ)
-150.58%52.62%-459.76%112.98%-288.11%42.57%485.67%-6.66%-290.76%116.27%-330.90%472.49%-199.83%120.08%-236.63%130.15%-246.98%195.56%-254.11%138.90%
Net Income Growth (1y)
-18.11%100.06%-138.09%-13.19%-7.75%-113,210.47%-27.17%1.32%26.06%11.82%34.98%16.25%-6.43%30.12%8.10%23.23%37.55%35.25%28.67%16.23%
Net Income Growth (3y)
-21.59%26.05%-35.52%-24.86%-18.42%-16.81%-22.43%-9.12%2.01%13.97%-25.33%2.20%5.35%-787.47%8.75%14.07%21.09%26.38%24.74%18.64%
Net Income Growth (5y)
-107.53%10.10%-7.45%-22.97%-15.53%-9.98%-5.50%0.36%-1.86%3.53%8.96%22.04%-5.23%9.66%
Net Income (QoQ)
-10.22%100.11%-91,503.49%-2.14%-4.92%-15.47%-2.77%20.74%21.39%-37.71%24.22%-2.09%0.10%9.58%0.34%14.72%18.73%6.26%-9.78%-0.16%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-18.11%100.06%-138.09%-13.19%-7.75%-113,210.47%-27.17%1.32%26.06%11.82%34.98%16.25%-6.43%30.12%8.10%23.23%37.55%35.25%28.67%16.23%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-21.59%26.05%-35.52%-24.86%-18.42%-16.81%-22.43%-9.12%2.01%13.97%-25.33%2.20%5.35%-787.47%8.75%14.07%21.09%26.38%24.74%18.64%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-107.53%10.10%-7.45%-22.97%-15.53%-9.98%-5.50%0.36%-1.86%3.53%8.96%22.04%-5.23%9.66%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-10.22%100.11%-91,503.49%-2.14%-4.92%-15.47%-2.77%20.74%21.39%-37.71%24.22%-2.09%0.10%9.58%0.34%14.72%18.73%6.26%-9.78%-0.16%
Net Margin Growth (1y)
-20.15M3.58M-15.24M-37.41M-13.17M-23.47M2.89M-3.43M3.78M
Net Margin Growth (3y)
-29.54M35.92M
Net Margin Growth (5y)
16.03M
Net Margin (QoQ)
0.17M15.96M-20.16M7.61M-18.66M-6.21M4.09M-2.69M7.70M-12.53M11.30M
Operating Income Growth (1y)Op. Inc Growth (1y)
-14.15%102.46%-141.00%-7.87%-6.23%-5,747.04%-23.84%-5.12%23.65%11.71%29.86%11.31%-13.93%28.93%6.21%20.46%37.44%29.90%29.30%17.42%
Operating Income Growth (3y)Op. Inc Growth (3y)
-51.84%27.07%-29.95%-18.57%-14.47%-14.29%-19.77%-8.44%2.53%-7.06%-27.92%-0.19%2.60%-234.53%6.60%9.48%18.36%23.95%22.52%16.48%
Operating Income Growth (5y)Op. Inc Growth (5y)
-107.16%9.82%-23.21%-20.83%-13.77%-9.22%-5.46%1.30%-2.48%2.09%7.98%9.37%-6.78%7.96%
Operating Income (QoQ)Op. Inc (QoQ)
-9.35%102.20%-4,787.40%4.25%-7.69%-16.83%-2.80%18.72%21.78%-35.10%18.34%-2.77%-0.48%15.72%-7.77%12.84%20.98%5.56%-8.70%-1.80%
Operating Margin Growth (1y)
-20.51M4.17M-14.71M-37.08M-12.51M-24.64M1.93M-3.45M1.44M
Operating Margin Growth (3y)
-31.58M36.51M
Operating Margin Growth (5y)
16.04M
Operating Margin (QoQ)
0.29M15.85M-20.52M8.55M-18.59M-6.52M4.04M-3.58M7.97M-11.89M8.94M
Profit After Tax Growth (1y)PAT Growth (1y)
-16.74%102.76%-139.52%-8.37%-5.48%-5,046.54%-22.02%-0.60%30.33%15.80%33.97%13.44%-14.75%27.02%6.63%23.39%36.60%32.13%28.43%16.28%
Profit After Tax Growth (3y)PAT Growth (3y)
-21.11%27.28%-36.11%-22.80%-17.12%-15.32%-21.22%-7.98%4.98%-4.76%-24.50%1.91%5.52%-218.79%9.05%12.62%20.27%25.28%23.87%17.81%
Profit After Tax Growth (5y)PAT Growth (5y)
-106.30%10.66%-5.48%-20.91%-15.23%-10.03%-5.13%1.18%-1.89%3.55%9.00%10.65%-5.22%9.55%
Profit After Tax (QoQ)PAT (QoQ)
-9.76%102.45%-4,300.85%4.05%-6.83%-14.88%-3.63%20.89%26.02%-38.83%18.74%-3.70%1.92%11.70%-3.96%14.92%18.82%5.47%-9.63%0.47%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
22.63%3.49%-2.39%-6.57%-9.09%-8.25%-8.61%-9.24%-10.15%-11.84%-12.67%-13.45%-13.46%-13.49%-13.49%-14.36%-14.71%-15.36%-15.63%-14.55%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
199.35%142.78%80.54%48.47%35.56%25.97%18.30%7.94%0.06%-5.76%-7.99%-9.80%-10.92%-11.22%-11.62%-12.38%-12.79%-13.58%-13.94%-14.12%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
85.41%63.19%36.26%20.79%14.14%8.80%4.58%-1.40%-5.86%-9.33%-10.68%-11.69%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
0.34%-2.30%-2.27%-2.48%-2.37%-1.40%-2.65%-3.15%-3.35%-3.26%-3.57%-4.01%-3.36%-3.30%-3.56%-4.98%-3.76%-4.03%-3.87%-3.77%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-305.00362.00-319.00-324.00-284.000.00M0.00M0.00M0.00M-706.00-64.00266.00-80.00112.00-214.00-455.00-162.00-16.00424.000.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M936.00-413.00-391.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-609.00146.000.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-194.00581.00-540.00-170.00-154.000.00M-577.00-147.00219.00-201.0065.00182.00-126.00-9.00-261.00-59.00166.00138.00178.00783.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-265.00512.00-286.00-338.00-313.000.00M0.00M0.00M0.00M-941.00-226.0082.00-283.00-9.00-288.00-567.00-284.00-173.00358.000.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M766.00-565.00-206.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-156.00985.00
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-211.00623.00-550.00-199.00-187.000.00M-710.00-190.00267.00-309.005.00119.00-98.00-35.00-274.00-161.00185.0077.00257.00951.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-375.00458.00-319.00-489.00-536.000.00M0.00M0.00M0.00M-969.00-143.00300.00-215.00-54.00-487.00-944.00-743.00-571.0073.000.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.01M957.00-571.00-623.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-557.000.00M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-225.00613.00-628.00-249.00-272.000.00M-843.00-215.00357.00-268.00-17.00228.00-158.00-107.00-450.00-230.0044.0065.00194.000.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-20.51M4.17M-14.71M-37.08M-12.51M-24.64M1.93M-3.45M1.44M-7.86M-40.63M-83.65M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-31.58M-28.32M-53.41M-124.18M36.51M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
16.04M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.29M15.85M-20.52M8.55M-18.59M-6.52M4.04M-3.58M7.97M-11.89M8.94M-12.87M-24.79M-54.92M
Revenue Growth (1y)
-99.90%45.45%-44.90%-99.97%-23.08%-65.63%-18.52%-19.23%-26.67%
Revenue Growth (3y)
-91.69%495.25%
Revenue Growth (5y)
153.87%
Revenue (QoQ)
11.36%154,289.80%-99.95%64.10%-57.81%-3.70%15.38%-26.67%0.00%-4.55%4.76%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
17.02%33.93%32.89%8.31%1.40%-21.74%-15.89%-27.51%-27.40%-11.67%-36.47%-18.29%-12.81%-15.49%2.10%-35.95%-35.37%-36.84%-32.07%43.24%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
65.04%55.41%41.56%25.84%18.11%7.52%9.71%-0.35%-4.85%-2.54%-10.78%-13.75%-13.74%-16.40%-18.29%-27.61%-25.76%-22.17%-23.91%-9.16%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
15.55%27.05%21.01%8.67%3.37%0.85%-1.49%-3.05%-12.33%-13.46%-13.15%-13.21%-10.06%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-1.32%5.66%1.27%2.58%-7.61%-18.45%8.84%-11.59%-7.47%-0.79%-21.72%13.71%-1.27%-3.84%-5.42%-28.67%-0.38%-6.03%1.72%50.42%

Allogene Therapeutics Growth Metrics API

Pull Allogene Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ALLO&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY